Disease detection at an early stage is one of the biggest challenges biochemists and materials scientists are trying to meet by combining their expertise at Missouri S&T. The researchers used nanotechnology in biomedical diagnostics—a process called nanodiagnostics—to create a new, ultrasensitive DNA biosensor. The new sensor could potentially detect DNA-based biomarkers for early diagnosis of cancer and genetic disorders, as well as monitor patient responses to therapies.